Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
- Nathan P, Hassel JC, Rutkowski P, et al. Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma. N Engl J Med. 2021 Sep 23;385(13):1196-1206.
- Joshua AM, Baurain J-F, Piperno-Neumann S, et al. Overall survival benefit from tebentafusp in patients with best response of progressive disease. J Clin Oncol. 2021;39(Suppl_15): 9509-9509.
Disclosure statements are available on the authors' profiles: